These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34269698)

  • 1. Monitoring Antihypertensive Medication Adherence by Liquid Chromatography-Tandem Mass Spectrometry: Method Establishment and Clinical Application.
    Wang Y; Wang JW; Wang Y; Yang B; Yinghua Du A; Kong Z; Chen M; Wang J
    J Cardiovasc Pharmacol; 2021 Oct; 78(4):581-596. PubMed ID: 34269698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for non-adherence to antihypertensive treatment as a part of the diagnostic pathway to renal denervation.
    Patel P; Gupta PK; White CM; Stanley AG; Williams B; Tomaszewski M
    J Hum Hypertens; 2016 Jun; 30(6):368-73. PubMed ID: 26446393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis.
    Tomaszewski M; White C; Patel P; Masca N; Damani R; Hepworth J; Samani NJ; Gupta P; Madira W; Stanley A; Williams B
    Heart; 2014 Jun; 100(11):855-61. PubMed ID: 24694797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood pressure reductions following catheter-based renal denervation are not related to improvements in adherence to antihypertensive drugs measured by urine/plasma toxicological analysis.
    Ewen S; Meyer MR; Cremers B; Laufs U; Helfer AG; Linz D; Kindermann I; Ukena C; Burnier M; Wagenpfeil S; Maurer HH; Böhm M; Mahfoud F
    Clin Res Cardiol; 2015 Dec; 104(12):1097-105. PubMed ID: 26306594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing Adherence to Antihypertensive Medication by Means of Dose-Dependent Reference Plasma Concentration Ranges and Ultra-High Performance Liquid Chromatography-Ion Trap Mass Spectrometry Analysis.
    Wagmann L; Vollmer AC; Lauder L; Mahfoud F; Meyer MR
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33803489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic drug monitoring-guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherence.
    Avataneo V; De Nicolò A; Rabbia F; Perlo E; Burrello J; Berra E; Pappaccogli M; Cusato J; D'Avolio A; Di Perri G; Veglio F
    Br J Clin Pharmacol; 2018 Nov; 84(11):2535-2543. PubMed ID: 29971815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of adherence to diuretics and β-blockers by serum drug monitoring in comparison to urine analysis.
    Ritscher S; Georges C; Wunder C; Wallemacq P; Persu A; Toennes SW
    Blood Press; 2020 Oct; 29(5):291-298. PubMed ID: 32400211
    [No Abstract]   [Full Text] [Related]  

  • 8. Routine urinary detection of antihypertensive drugs for systematic evaluation of adherence to treatment in hypertensive patients.
    Hamdidouche I; Jullien V; Boutouyrie P; Billaud E; Azizi M; Laurent S
    J Hypertens; 2017 Sep; 35(9):1891-1898. PubMed ID: 28505066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring adherence to antihypertensive medication using an objective test in older adults attending primary care: cross-sectional study.
    Sheppard JP; Albasri A; Gupta P; Patel P; Khunti K; Martin U; McManus RJ; Hobbs FDR
    J Hum Hypertens; 2022 Dec; 36(12):1106-1112. PubMed ID: 34876657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel 'Dilute-and-Shoot' Liquid Chromatography-Tandem Mass Spectrometry Method for the Screening of Antihypertensive Drugs in Urine.
    Lawson AJ; Shipman KE; George S; Dasgupta I
    J Anal Toxicol; 2016; 40(1):17-27. PubMed ID: 26333988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Nonadherence to Antihypertensive Treatment by Measurements of Serum Drug Concentrations.
    Bergland OU; Halvorsen LV; Søraas CL; Hjørnholm U; Kjær VN; Rognstad S; Brobak KM; Aune A; Olsen E; Fauchald YM; Heimark S; Thorstensen CW; Liestøl K; Solbu MD; Gerdts E; Mo R; Rostrup M; Kjeldsen SE; Høieggen A; Opdal MS; Larstorp ACK; Fadl Elmula FEM
    Hypertension; 2021 Sep; 78(3):617-628. PubMed ID: 34275336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonadherence to antihypertensive medications is related to pill burden in apparent treatment-resistant hypertensive individuals.
    Lawson AJ; Hameed MA; Brown R; Cappuccio FP; George S; Hinton T; Kapil V; Lenart J; Lobo MD; Martin U; Menon M; Nightingale A; Rylance PB; Webb DJ; Dasgupta I
    J Hypertens; 2020 Jun; 38(6):1165-1173. PubMed ID: 32371807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to Antihypertensive Treatment and the Blood Pressure-Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) Trial.
    Azizi M; Pereira H; Hamdidouche I; Gosse P; Monge M; Bobrie G; Delsart P; Mounier-Véhier C; Courand PY; Lantelme P; Denolle T; Dourmap-Collas C; Girerd X; Michel Halimi J; Zannad F; Ormezzano O; Vaïsse B; Herpin D; Ribstein J; Chamontin B; Mourad JJ; Ferrari E; Plouin PF; Jullien V; Sapoval M; Chatellier G;
    Circulation; 2016 Sep; 134(12):847-57. PubMed ID: 27576780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A practical approach for measurement of antihypertensive medication adherence in patients with resistant hypertension.
    Corrêa NB; de Faria AP; Ritter AM; Sabbatini AR; Almeida A; Brunelli V; Calhoun DA; Moreno H; Modolo R
    J Am Soc Hypertens; 2016 Jun; 10(6):510-516.e1. PubMed ID: 27161936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Drug Monitoring to Assess Drug Adherence in Assumed Resistant Hypertension: A Comparison With Directly Observed Therapy in Three Nonadherent Patients.
    Šíma M; Slanař O
    J Cardiovasc Pharmacol; 2019 Feb; 73(2):125. PubMed ID: 30531438
    [No Abstract]   [Full Text] [Related]  

  • 17. Urine Concentration Does Not Affect Biochemical Testing for Non-adherence.
    Burns AD; Alghamadi R; Iqbal A; Davies T; Lane D; Patel P; Gupta P
    J Anal Toxicol; 2021 Mar; 45(3):e1-e5. PubMed ID: 33300570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to antihypertensive drug treatment in patients with apparently treatment-resistant hypertension in the INSPiRED pilot study.
    Wunder C; Persu A; Lengelé JP; Mg Georges C; Renkin J; Pasquet A; Carlier M; Zhang ZY; Staessen JA;
    Blood Press; 2019 Jun; 28(3):168-172. PubMed ID: 30942111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of thorough investigation of resistant hypertension before renal denervation: should compliance to treatment be evaluated systematically?
    Rosa J; Zelinka T; Petrák O; Štrauch B; Šomlóová Z; Indra T; Holaj R; Čurila K; Toušek P; Šenitko M; Widimský P; Widimský J
    J Hum Hypertens; 2014 Nov; 28(11):684-8. PubMed ID: 24500722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring adherence to therapy in apparent treatment-resistant hypertension: a feasibility study in Irish primary care.
    Hayes P; Casey M; Glynn LG; Molloy GJ; Durand H; O'Brien E; Dolan E; Das K; Newell J; Finn D; Harhen B; Conneely A; Murphy AW
    Br J Gen Pract; 2019 Sep; 69(686):e621-e628. PubMed ID: 31358495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.